Expression of Bcl-2, Bcl-x, and Bax proteins in astrocytomas in relation to patient survival

Chiou SK, Rao L, White E (1994) Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol 14:2556–2563 Lowe SW, Ruley HE, Jacks T, et al (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957–967 Vaux DL, Cory S, Adams JM (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440–442 Boise LH, Gonzàlez-Garcia M, Postema CE, et al (1993) Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597–608 Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74:609–619 Tsujimoto Y, Finger LR, Yunis J, et al (1984) Cloning of the chromosome breakpoint of neoplastic B cells with the t(1;18) chromosome translocation. Science 226:1097–1099 Oltvai ZN, Korsmeyer SJ (1994) Checkpoints of dueling dimers foil death wishes. Cell 79:189–192 Dole M, Nuñez G, Merchant AK, et al (1994) Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res 54:3253–3259 Bargou RC, Wagener C, Bommert K, et al (1996) Overexpression of the death-promoting gene bax-α which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice. J Clin Invest 97:2651–2659 Strobel T, Swanson L, Korsmeyer S, et al (1996) Bax enhances paclitaxel-induced apoptosis through a p53-independent pathway. Proc Natl Acad Sci USA 93:14094–14099 Wagener C, Bargou RC, Daniel PT, et al (1996) Induction of the cell-promoting gene bax-α sensitized cultured breast-cancer cells to drug-induced apoptosis. Int J Cancer 67:138–141 Hockenbery DM (1994) Bcl-2 in cancer, development of apoptosis. J Cell Sci 18 (Suppl):51–55 Knudson CM, Tung KSK, Tourtellotte WG, et al (1995) Baxdeficient mice with lymphoid hyperplasia and male germ cell death. Science 270:96–99 Motoyama N, Wang F, Roth KA, et al (1995) Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267:1506–1510 Shapiro WR (1983) Treatment of neuroectodermal brain tumors. Ann Neurol 12:231–237 Mizumatsu S, Tamiya T, Ono Y, et al (1999) Expression of cell cycle regulator p27 is correlated with survival of patients with astrocytoma Clin Cancer Res 5:551–557 Burger PC (1986) Malignant astrocytic neoplasms: classification, pathologic anatomy, and response to treatment. Semin Oncol 13:16–26 Burger PC, Green SB (1987) Patient age, histological features, and length of survival in patients with glioblastoma multiforme. Cancer 59:1617–1625 Burger PC, Vogel FS, Green SB, et al (1985) Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer 56:1106–1112 Newcomb EW, Bhalla SK, Parrish CL, et al (1997) Bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status. Acta Neuropathol 94:369–375 Ehrmann J Jr, Kolar Z, Vojtesek B, et al (1997) Prognostic factors in astrocytomas: relationship of p53, MDM-2, BCL-2 and PCNA immunohistochemical expression to tumor grade and overall patient survival. Neoplasma 44:299–304 Fels C, Schafer C, Huppe B, et al (2000) Bcl-2 expression in high-grade human glioma: a clinical and experimental study. J Neurooncol 48:207–216 Hara A, Hirose Y, Yoshimi N, et al (1997) Expression of Bax and Bcl-2 proteins, regulators of programmed cell death, in human brain tumors. Neurol Res 19:623–628 Korshunov A, Golanov A, Sycheva R, et al (1999) Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases. J Clin Pathol 52:574–580 Newcomb EW, Cohen H, Lee SR, et al (1998) Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53,EGFR, MDM2 or Bcl-2 genes. Brain Pathol 8: 655–667 Schiffer D, Cavalla P, Migheli A, et al (1996) Bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study. J Neurooncol 27:101–109 Strik H, Deininger M, Streffer J, et al (1999) BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy. J Neurol Neurosurg Psychiatry 67:763–768 Takekawa Y, Sawada T, Sakurai I (1999) Expression of apoptosis and its related protein in astrocytic tumors. Brain Tumor Pathol 16:11–16 Walker MD, Alexander E Jr, Hunt WE, et al (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A co-operative clinical trial. J Neurosurg 49:333–343 Yew DT, Wang HH, Zheng DR (1998) Apoptosis in astrocytomas with different grades of malignancy. Acta Neurochir 140:341–347 Rieger L, Weller M, Bornemann A, et al (1998) BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study. J Neurol Sci 155:68–75 Zha H, Aime-Sempe C, Sato T, et al (1996) Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J Biol Chem 271:7440–7444